This study investigates pancreatic adenocarcinoma. The purpose of this study is to explore the effects of Cyberknife, a type of radiation therapy, on patients with specific stages of this condition.
The study evaluates the safety of Cyberknife compared to another radiation therapy method. It focuses on understanding how these treatments affect the condition and the quality of life for patients.
- Who can participate: Adults aged 18 and older with Stage I to Stage III pancreatic cancer may participate. Key factors include completion of neoadjuvant chemotherapy and approval for radiation therapy by a tumor board.
- Study details: Participants will receive either investigational radiation therapy or another radiation therapy. They will be monitored for changes in their condition and quality of life.
- Study timelines: The study will last 12 months.
How understandable was the trial content above?
Hard to understand
Easy to understand